Sardesai, S., Badawi, M., Mrozek, E., Morgan, E., Phelps, M., Stephens, J., . . . Wesolowski, R. (2020). A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Invest New Drugs.
Citação norma ChicagoSardesai, Sagar, et al. "A Phase I Study of an Oral Selective Gamma Secretase (GS) Inhibitor RO4929097 in Combination With Neoadjuvant Paclitaxel and Carboplatin in Triple Negative Breast Cancer." Invest New Drugs 2020.
MLA citiranjeSardesai, Sagar, et al. "A Phase I Study of an Oral Selective Gamma Secretase (GS) Inhibitor RO4929097 in Combination With Neoadjuvant Paclitaxel and Carboplatin in Triple Negative Breast Cancer." Invest New Drugs 2020.